Lialda

Lialda is a brand name of mesalamine, approved by the FDA in the following formulation(s):

LIALDA (mesalamine - tablet, delayed release; oral)

• 
  Manufacturer: SHIRE
  
  Approval date: January 16, 2007
  
  Strength(s): 1.2GM ^[RLD]

Has a generic version of Lialda been approved?

No. There is currently no therapeutically equivalent version of Lialda available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Lialda. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Mesalazine controlled release oral pharmaceutical compositions
  Patent 6,773,720
  Issued: August 10, 2004
  Inventor(s): Roberto; Villa & Massimo; Pedrani & Mauro; Ajani & Lorenzo; Fossati
  Assignee(s): Cosmo S.p.A.
  Controlled-release oral pharmaceutical compositions containing as active ingredient 5-amino-salicylic acid, comprising: a) an inner lipophilic matrix consisting of substances with a melting point below 90° C. in which the active ingredient is at least partly inglobated; b) an outer hydrophilic matrix in which the lipophilic matrix is dispersed; c) optionally other excipients.
  
  Patent expiration dates:
  
  
  • June 8, 2020
    
    ✓ 
    Drug product
  
  

Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

• Exclusivity expiration dates:
  • July 14, 2014 - MAINTENANCE OF REMISSION OF ULCERATIVE COLITIS
  
  

See also...

• Lialda Consumer Information (Drugs.com)
• Lialda Delayed-Release Tablets Consumer Information (Wolters Kluwer)
• Lialda Consumer Information (Cerner Multum)
• Lialda Advanced Consumer Information (Micromedex)
• Mesalamine Controlled-Release Capsules Consumer Information (Wolters Kluwer)
• Mesalamine Delayed-Release Tablets Consumer Information (Wolters Kluwer)
• Mesalamine Enema Consumer Information (Wolters Kluwer)
• Mesalamine Extended-Release Capsules Consumer Information (Wolters Kluwer)
• Mesalamine Suppositories Consumer Information (Wolters Kluwer)
• Mesalamine Consumer Information (Cerner Multum)
• Mesalamine rectal Consumer Information (Cerner Multum)
• Mesalamine Advanced Consumer Information (Micromedex)
• Mesalamine Rectal Advanced Consumer Information (Micromedex)
• SfRowasa Advanced Consumer Information (Micromedex)
• Mesalamine AHFS DI Monographs (ASHP)